Comparison between Claris Lifesciences IPO and PGCIL FPO.
Claris Lifesciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE while PGCIL FPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Claris Lifesciences IPO is up to ₹300.00 Cr whereas the issue size of the PGCIL FPO is up to ₹6,958.64 Cr. The final issue price of Claris Lifesciences IPO is ₹228.00 per share and of PGCIL FPO is ₹90.00 per share.
| Claris Lifesciences IPO | PGCIL FPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹228.00 per share | ₹85.00 per share |
| Issue Price (Upper) | ₹235.00 per share | ₹90.00 per share |
| Issue Price (Final) | ₹228.00 per share | ₹90.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹4.50 per share |
| Discount (Employee) | ₹4.50 per share | |
| Market Lot Size | 22 shares | 150 shares |
| Fresh Issue Size | 1,26,32,477 shares | 60,18,64,295 shares |
| Fresh Issue Size (Amount) | up to ₹300.00 Cr | up to ₹5,321.31 Cr |
| OFS Issue Size | 0 shares | 18,51,89,014 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹1,637.33 Cr |
| Issue Size Total | 1,26,32,477 shares | 78,70,53,309 shares |
| Issue Size Total (Amount) | up to ₹300.00 Cr | up to ₹6,958.64 Cr |
Claris Lifesciences IPO opens on Nov 24, 2010, while PGCIL FPO opens on Dec 03, 2013. The closing date of Claris Lifesciences IPO and PGCIL FPO is Dec 02, 2010, and Dec 06, 2013, respectively.
| Claris Lifesciences IPO | PGCIL FPO | |
|---|---|---|
| Anchor Bid Date | Nov 23, 2010 | |
| Issue Open | Nov 24, 2010 | Dec 03, 2013 |
| Issue Close | Dec 02, 2010 | Dec 06, 2013 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Dec 20, 2010 | Dec 19, 2013 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Claris Lifesciences IPO P/E ratio is , as compared to PGCIL FPO P/E ratio of .
| Claris Lifesciences IPO | PGCIL FPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 86.03 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 0.69 | 86.36 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹1455.05 Cr. | ₹47084.31 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 24.15 | 16.15 |
In the Claris Lifesciences IPO Retail Individual Investors (RII) are offered 37,89,743 shares while in PGCIL FPO retail investors are offered 37,89,743 shares. Qualified Institutional Buyers (QIB) are offered 57,36,484 shares in Claris Lifesciences IPO and 39,20,26,655 shares in PGCIL FPO.
| Claris Lifesciences IPO | PGCIL FPO | |
|---|---|---|
| Anchor Investor Reservation | 18,43,003 shares | |
| Market Maker Reservation | ||
| QIB | 57,36,484 shares | 39,20,26,655 shares |
| NII | 12,63,247 shares | 11,76,07,996 shares |
| RII | 37,89,743 shares | 27,44,18,658 shares |
| Employee | 30,00,000 shares | |
| Others | ||
| Total | 1,26,32,477 shares | 78,70,53,309 shares |
Claris Lifesciences IPO subscribed 1.05x in total, whereas PGCIL FPO subscribed 0.00x.
| Claris Lifesciences IPO | PGCIL FPO | |
|---|---|---|
| QIB (times) | 1.04x | 0.00x |
| NII (times) | 1.72x | 0.00x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.35x | 0.00x |
| Employee (times) | 0.00x | |
| Other (times) | ||
| Total (times) | 1.05x | 0.00x |
